NASDAQ: CTOR
Citius Oncology Inc Stock Forecast, Predictions & Price Target

Analyst price target for CTOR

Based on 1 analyst offering 12 month price targets for Citius Oncology Inc

Min Forecast
$3.00+354.55%
Avg Forecast
$3.00+354.55%
Max Forecast
$3.00+354.55%

Should I buy or sell CTOR stock?

Based on 1 analyst offering ratings for Citius Oncology Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CTOR stock forecasts and price targets.

CTOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-27

1 of 1

CTOR vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CTOR$0.66$3.00+354.55%Strong Buy
ASRT$0.59$3.50+494.23%Buy
SCYX$0.94N/AN/A
RMTI$1.05$4.00+280.95%Strong Buy
INCR$1.38N/AN/A

Citius Oncology Stock Forecast FAQ

Is Citius Oncology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CTOR) stock is to Strong Buy CTOR stock.

Out of 1 analyst, 1 (100%) are recommending CTOR as a Strong Buy, 0 (0%) are recommending CTOR as a Buy, 0 (0%) are recommending CTOR as a Hold, 0 (0%) are recommending CTOR as a Sell, and 0 (0%) are recommending CTOR as a Strong Sell.

If you're new to stock investing, here's how to buy Citius Oncology stock.

What is CTOR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CTOR price target, the average CTOR price target is $3.00, with the highest CTOR stock price forecast at $3.00 and the lowest CTOR stock price forecast at $3.00.

The Wall Street analyst predicted that Citius Oncology's share price could reach $3.00 by Nov 27, 2025. The average Citius Oncology stock price prediction forecasts a potential upside of 354.55% from the current CTOR share price of $0.66.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.